Insufficient autophagy in idiopathic pulmonary fibrosis

Author:

Araya Jun1,Kojima Jun1,Takasaka Naoki1,Ito Saburo1,Fujii Satoko1,Hara Hiromichi1,Yanagisawa Haruhiko1,Kobayashi Kenji1,Tsurushige Chikako1,Kawaishi Makoto1,Kamiya Noriki2,Hirano Jun2,Odaka Makoto2,Morikawa Toshiaki2,Nishimura Stephen L.3,Kawabata Yoshinori4,Hano Hiroshi5,Nakayama Katsutoshi1,Kuwano Kazuyoshi1

Affiliation:

1. Division of Respiratory Diseases, Department of Internal Medicine,

2. Division of Chest Diseases, Department of Surgery,

3. Department of Pathology, University of California, San Francisco, California

4. Section of Pathology, Saitama Cardiovascular and Respiratory Center, Saitama;

5. Department of Pathology, Jikei University School of Medicine, Jikei;

Abstract

Autophagy, a process that helps maintain homeostatic balance between the synthesis, degradation, and recycling of organelles and proteins to meet metabolic demands, plays an important regulatory role in cellular senescence and differentiation. Here we examine the regulatory role of autophagy in idiopathic pulmonary fibrosis (IPF) pathogenesis. We test the hypothesis that epithelial cell senescence and myofibroblast differentiation are consequences of insufficient autophagy. Using biochemical evaluation of in vitro models, we find that autophagy inhibition is sufficient to induce acceleration of epithelial cell senescence and myofibroblast differentiation in lung fibroblasts. Immunohistochemical evaluation of human IPF biospecimens reveals that epithelial cells show increased cellular senescence, and both overlaying epithelial cells and fibroblasts in fibroblastic foci (FF) express both ubiquitinated proteins and p62. These findings suggest that insufficient autophagy is an underlying mechanism of both accelerated cellular senescence and myofibroblast differentiation in a cell-type-specific manner and is a promising clue for understanding the pathogenesis of IPF.

Publisher

American Physiological Society

Subject

Cell Biology,Physiology (medical),Pulmonary and Respiratory Medicine,Physiology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3